IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more
IOL Chemicals and Pharmaceuticals Limited - Asset Resilience Ratio
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has an Asset Resilience Ratio of 13.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2025)
This chart shows how IOL Chemicals and Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down IOL Chemicals and Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹1.68 Billion | 6.97% |
| Short-term Investments | ₹1.52 Billion | 6.3% |
| Total Liquid Assets | ₹3.20 Billion | 13.27% |
Asset Resilience Insights
- Moderate Liquidity: IOL Chemicals and Pharmaceuticals Limited has 13.27% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
IOL Chemicals and Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio
Compare IOL Chemicals and Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for IOL Chemicals and Pharmaceuticals Limited (2005–2025)
The table below shows the annual Asset Resilience Ratio data for IOL Chemicals and Pharmaceuticals Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 5.50% | ₹1.31 Billion | ₹23.82 Billion | -0.50pp |
| 2024-03-31 | 6.01% | ₹1.35 Billion | ₹22.44 Billion | +4.93pp |
| 2023-03-31 | 1.08% | ₹217.50 Million | ₹20.22 Billion | -4.86pp |
| 2022-03-31 | 5.94% | ₹1.17 Billion | ₹19.62 Billion | -13.89pp |
| 2021-03-31 | 19.83% | ₹3.19 Billion | ₹16.10 Billion | +11.05pp |
| 2020-03-31 | 8.78% | ₹1.03 Billion | ₹11.70 Billion | +8.77pp |
| 2019-03-31 | 0.01% | ₹600.00K | ₹9.42 Billion | -2.03pp |
| 2018-03-31 | 2.04% | ₹173.80 Million | ₹8.52 Billion | +0.03pp |
| 2017-03-31 | 2.01% | ₹164.40 Million | ₹8.17 Billion | +2.01pp |
| 2016-03-31 | 0.01% | ₹457.23K | ₹7.76 Billion | +0.00pp |
| 2015-03-31 | 0.00% | ₹99.90K | ₹7.02 Billion | -1.20pp |
| 2012-03-31 | 1.20% | ₹82.56 Million | ₹6.87 Billion | -1.02pp |
| 2006-03-31 | 2.22% | ₹21.03 Million | ₹946.52 Million | +0.80pp |
| 2005-03-31 | 1.42% | ₹8.55 Million | ₹600.82 Million | -- |